MedTrace Logo

Impact of Parental Perfectionistic Cognitions Self-compassion Intervention Effects on Shame in Child Health Context

NCT03504605 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 344

Last updated 2019-07-26

No results posted yet for this study

Summary

Parents of children with long-term health conditions (LTCs) can experience shame related to parenting. Whilst self-compassion interventions (SCIs) can reduce parental shame, this has not been studied with parents of children with LTCs. Perfectionistic cognitions may also moderate the effects of SCIs. This study will test an online SCI with parents of children with type 1 diabetes, epilepsy or asthma. Parents will complete online questionnaires pre- and post a SCI/control intervention. Hypotheses will be tested using analysis of covariance and moderation analysis. Findings will enhance knowledge of vulnerability factors to distress for parents of children with LTCs, and inform interventions.

Conditions

  • Diabetes Mellitus, Type 1
  • Epilepsy
  • Asthma
  • Shame
  • Self-Compassion
  • Stress
  • Perfectionistic Cognitions

Interventions

OTHER

Online self-compassion intervention

Parents are asked to write in an online text box about a parenting event in which they felt shame. They are then given a validated set of instructions asking them to reflect on the event and write self-compassionate responses.

Sponsors & Collaborators

  • Sheffield Children's NHS Foundation Trust

    collaborator OTHER

  • Alder Hey Children's Hospital NHS Foundation Trust

    collaborator UNKNOWN

  • Chesterfield Royal NHS Foundation Trust

    collaborator UNKNOWN

  • University of Sheffield

    lead OTHER

Principal Investigators

  • Catherine Lilley · University of Sheffield

  • Georgina Rowse · University of Sheffield

  • Fuschia Sirois · University of Sheffield

  • Amrit Sinha · University of Sheffield

  • Kirsteen Meheran · University of Sheffield

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-08-15
Primary Completion
2019-01-23
Completion
2019-07-25

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03504605 on ClinicalTrials.gov